Kato et al. (2017) found that novel porphyrin lipid NPs targeting folate receptor 1 (FOLR1) can improve the effectiveness and specificity of photodynamic therapy (PDT), which is helpful for the minimally invasive intervention of peripheral lung cancer and advanced lung cancer metastatic lymph nodes. The gene discussed is FOLR1; the disease is lung carcinoma.